Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune 1 Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV.

News Source:- Money Control